AstraZeneca

Propeller Health gets nod for use of sensor, app product with AstraZeneca inhaler
Propeller Health gets nod for use of sensor, app product with AstraZeneca inhaler
MedCity News
FDA
AstraZeneca
Propeller Health
devices
inhalers
Symbicort
asthma
COPD
Flag link:
AstraZeneca's COVID-19 vaccine enters phase 2/3 clinical trial
AstraZeneca's COVID-19 vaccine enters phase 2/3 clinical trial
Fierce Biotech
University of Oxford
AstraZeneca
clinical trials
vaccines
AZD1222
UK
COVID-19
Flag link:
AstraZeneca Receives $1 Billion From U.S. Government To Produce Oxford Coronavirus Vaccine
AstraZeneca Receives $1 Billion From U.S. Government To Produce Oxford Coronavirus Vaccine
Forbes
AstraZeneca
BARDA
federal government
University of Oxford
COVID-19
vaccines
Flag link:
FDA Approves New Prostate Cancer Treatment From AstraZeneca and Merck
FDA Approves New Prostate Cancer Treatment From AstraZeneca and Merck
Motley Fool
AstraZeneca
Merck
Lynparza
prostate cancer
FDA
Flag link:
AstraZeneca-partnered RNA player Silence plans Nasdaq listing
AstraZeneca-partnered RNA player Silence plans Nasdaq listing
Fierce Biotech
Silence Therapeutics
RNA therapeutics
RNA
NASDAQ
AstraZeneca
gene silencing
Flag link:
AstraZeneca signed up to deliver U.K. shots first. Now it aims to supply COVID-19 vaccine worldwide: report
AstraZeneca signed up to deliver U.K. shots first. Now it aims to supply COVID-19 vaccine worldwide: report
Fierce Pharma
AstraZeneca
UK
University of Oxford
vaccines
COVID-19
pandemic
Flag link:
AstraZeneca Aims for 30 Million Doses of COVID-19 Vaccine for U.K. by September
AstraZeneca Aims for 30 Million Doses of COVID-19 Vaccine for U.K. by September
BioSpace
AstraZeneca
UK
University of Oxford
vaccines
COVID-19
Flag link:
AZ/Daiichi’s Enhertu gains second ‘breakthrough’ tag in space of a week
AZ/Daiichi’s Enhertu gains second ‘breakthrough’ tag in space of a week
Pharmaforum
AstraZeneca
Daiichi Sankyo
Enhertus
metastatic non-small-cell lung cancer
Flag link:
AstraZeneca tackles COPD, asthma patients' COVID-19 concerns in new YouTube series
AstraZeneca tackles COPD, asthma patients' COVID-19 concerns in new YouTube series
Fierce Pharma
AstraZeneca
YouTube
COPD
asthma
coronavirus
COVID-19
Flag link:
Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand
Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand
Yahoo/Benzinga
University of Oxford
AstraZeneca
Inovio
Moderna Therapeutics
pandemic
vaccines
COVID-19
Flag link:
AstraZeneca to unveil key data for cancer drugs at ASCO
AstraZeneca to unveil key data for cancer drugs at ASCO
Pharmaforum
AstraZeneca
ASCO 2020
Tagrisso
lung cancer
Enhertu
breast cancer
gastric cancer
colorectal cancer
Flag link:
AstraZeneca, Merck's star PARP inhibitor Lynparza expands reach in ovarian cancer with new US approval
AstraZeneca, Merck's star PARP inhibitor Lynparza expands reach in ovarian cancer with new US approval
Endpoints
AstraZeneca
Merck
Lynparza
ovarian cancer
Flag link:
AstraZeneca, Daiichi Sankyo get FDA breakthrough therapy status for gastric cancer drug
AstraZeneca, Daiichi Sankyo get FDA breakthrough therapy status for gastric cancer drug
Pharmaceutical Business Review
AstraZeneca
Daiichi Sankyo
FDA
Enhertu
gastric cancer
breakthrough therapy
Flag link:
From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now
From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now
Motley Fool
FDA
drug approvals
Gilead Sciences
remdesivir
AstraZeneca
Merck
Lynparza
Clovis Oncology
Rubraca
Bristol-Myers Squibb
Opdivo
Yervoy
Flag link:
Go or no go? Oncology dominates upcoming decisions
Go or no go? Oncology dominates upcoming decisions
EP Vantage
FDA
oncology
AstraZeneca
Lynparza
ovarian cancer
prostate cancer
Bristol-Myers Squibb
Opdivo
lung cancer
Flag link:
AstraZeneca, racing past rivals, throws its weight behind Oxford's COVID-19 vaccine
AstraZeneca, racing past rivals, throws its weight behind Oxford's COVID-19 vaccine
BioPharma Dive
AstraZeneca
vaccines
University of Oxford
COVID-19
pandemic
Flag link:
AZ maintains 2020 guidance as Q1 sales grow despite pandemic
AZ maintains 2020 guidance as Q1 sales grow despite pandemic
Pharmaforum
AstraZeneca
earnings
COVID-19
pandemic
Flag link:
Positive Prostate Cancer Results for Lynparza Are Bad News for Clovis Oncology
Positive Prostate Cancer Results for Lynparza Are Bad News for Clovis Oncology
Motley Fool
Clovis Oncology
Rubraca
AstraZeneca
Merck
Lynparza
prostate cancer
Flag link:
AstraZeneca and Merck's Lynparza Improves Survival in Prostate Cancer with Specific Repair Gene Mutations
AstraZeneca and Merck's Lynparza Improves Survival in Prostate Cancer with Specific Repair Gene Mutations
BioSpace
AstraZeneca
Merck
clinical trials
Lynparza
metastatic castration-resistant prostate cancer
prostate cancer
Flag link:
To Help High-Risk COVID-19 Patients, AstraZeneca's Testing a Diabetes Treatment
To Help High-Risk COVID-19 Patients, AstraZeneca's Testing a Diabetes Treatment
Motley Fool
AstraZeneca
diabetes
Farxiga
COVID-19
Flag link:

Pages